结节病

Lynch JP 3rd. Computed tomographic scanning in sarcoidosis. Semin Respir Crit Care Med. 2003;24:393-418.

• 摘要

1.  American Thoracic Society. Statement on sarcoidosis: joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG), adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160:736-755.

• 全文
• 摘要

2.  Rybicki BA, Iannuzzi MC, Frederick MM, et al. Familial aggregation of sarcoidosis: a case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med. 2001;164:2085-2091.

• 全文
• 摘要

3.  Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164:1885-1889.

• 全文
• 摘要

4.  Valeyre D, Soler P, Clerici C, et al. Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax. 1988;43:516-524.

• 摘要

5.  Rothova A. Ocular involvement in sarcoidosis. Br J Ophthalmol. 2000;84;110-116.

• 全文
• 摘要

6.  Lynch JP 3rd. Computed tomographic scanning in sarcoidosis. Semin Respir Crit Care Med. 2003;24:393-418.

• 摘要

7.  Varela-Lema L, Fernández-Villar A, Ruano-Ravina A. Effectiveness and safety of endobronchial ultrasound-transbronchial needle aspiration: a systematic review. Eur Respir J. 2009;33:1156-1164.

• 全文
• 摘要

8.  National Institute for Health and Care Excellence. Endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal masses. February 2008. http://www.nice.org.uk/ (last accessed 30 August 2017).

• 全文

9.  Agarwal R, Srinivasan A, Aggarwal AN, et al. Efficacy and safety of convex probe EBUS-TBNA in sarcoidosis: a systematic review and meta-analysis. Respir Med. 2012;106:883-892.

• 摘要

10.  Nunes H, Brillet PY, Valeyre D, et al. Imaging in sarcoidosis. Semin Respir Crit Care Med. 2007;28:102-120.

• 摘要

11.  Youssef G, Leung E, Mylonas I, et al. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience. J Nucl Med. 2012;53:241-248.

• 摘要

12.  Nobuhiro T, Atsuko T, Yoshikazu N, et al. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis. JACC Cardiovasc Imaging. 2010;3:1219-1228.

• 摘要

13.  Devine ST, Delgado JA, Lippmann ML. Hemoptysis as an initial presentation in sarcoidosis: How common is it?: a review. Clin Pulm Med. 2007;14:76-81.

14.  de Kleijn WP, De Vries J, Lower EE, et al. Fatigue in sarcoidosis: a systematic review. Curr Opin Pulm Med. 2009;15:499-506.

• 摘要

15.  Hirose Y, Ishida Y, Hayashida K, et al. Myocardial involvement in patients with sarcoidosis. An analysis of 75 patients. Clin Nucl Med. 1994;19:522-526.

• 摘要

16.  Bianco A, Spiteri MA. Peripheral anergy and local immune hyperactivation in sarcoidosis: a paradox or birds of a feather. Clin Exp Immunol. 1997;110:1-3.

• 全文
• 摘要

17.  Murdoch J, Muller NL. Pulmonary sarcoidosis: changes on follow-up CT examination. AJR Am J Roentgenol. 1992;159:473-477.

• 全文
• 摘要

18.  Bradley B, Branley HM, Egan JJ, et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax. 2008;63(suppl 5):v1-v58.

• 摘要

19.  Sharma OP. Vitamin D, calcium, and sarcoidosis. Chest. 1996;109:535-539.

• 摘要

20.  Agarwal R, Aggarwal AN, Gupta D. Efficacy and safety of conventional transbronchial needle aspiration in sarcoidosis: a systematic review and meta-analysis. Respir Care. 2013;58:683-693.

• 全文
• 摘要

21.  von Bartheld MB, Dekkers OM, Szlubowski A, et al. Endosonography vs conventional bronchoscopy for the diagnosis of sarcoidosis: the GRANULOMA randomized clinical trial. JAMA. 2013;309:2457-2464.

• 全文
• 摘要

22.  Royal College of Radiologists; Royal College of Physicians of London. Evidence-based indications for the use of PET-CT in the United Kingdom 2016. 2016. http://www.rcr.ac.uk (last accessed 30 August 2017).

• 全文

23.  Kennedy CC, Limper AH. Redefining the clinical spectrum of chronic pulmonary histoplasmosis: a retrospective case series of 46 patients. Medicine (Baltimore). 2007;86:252-258.

• 摘要

24.  Meyer KC. Beryllium and lung disease. Chest. 1994;106:942-946.

• 摘要

25.  Fink JN, Ortega HG, Reynolds HY, et al. Needs and opportunities for research in hypersensitivity pneumonitis. Am J Respir Crit Care Med. 2005;171:792-798.

• 全文
• 摘要

26.  Facco M, Trentin L, Nicolardi L, et al. T cells in the lung of patients with hypersensitivity pneumonitis accumulate in a clonal manner. J Leukoc Biol. 2004;75:798-804.

• 摘要

27.  Scadding JG. Prognosis of intrathoracic sarcoidosis in England: a review of 136 cases after five years' observation. Br Med J. 1961;2:1165-1172.

• 全文
• 摘要

28.  Paramothayan NS, Lasserson TJ, Jones P. Corticosteroids for pulmonary sarcoidosis. Cochrane Database Syst Rev. 2005;(2):CD001114.

• 全文
• 摘要

29.  Alberts C, van der Mark TW, Jansen HM; Dutch Study Group on Pulmonary Sarcoidosis. Inhaled budesonide in pulmonary sarcoidosis: a double-blind, placebo-controlled study. Eur Respir J. 1995;8:682-688.

• 全文
• 摘要

30.  Yeap SS, Hosking DJ. Management of corticosteroid-induced osteoporosis. Rheumatology. 2002;41:1088-1094.

• 全文
• 摘要

31.  Trulock EP, Edwards LB, Taylor DO, et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult lung and heart-lung transplant report - 2004. J Heart Lung Transplant. 2004;23:804-815.

• 摘要

32.  Khatri KA, Chotzen VA, Burrall BA. Lupus pernio: successful treatment with a potent topical corticosteroid. Arch Dermatol. 1995;131:617-618.

• 摘要

33.  Jones E, Callen JP. Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas. J Am Acad Dermatol. 1990;23:487-489.

• 摘要

34.  Sharma OP, Sharma AM. Sarcoidosis of the nervous system. A clinical approach. Arch Intern Med. 1991;151:1317-1321.

• 摘要

35.  Baughman RP, Drent M, Kavuru M, et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med. 2006;174:795-802.

• 全文
• 摘要

36.  Baughman RP, Judson MA, Teirstein AS, et al. Thalidomide for chronic sarcoidosis. Chest. 2002;122:227-232.

• 摘要

37.  Droitcourt C, Rybojad M, Porcher R, et al. A randomized, investigator-masked, double-blind, placebo-controlled trial on thalidomide in severe cutaneous sarcoidosis. Chest. 2014;146:1046-1054.

• 摘要

38.  Zabel P, Entzian P, Dalhoff K, et al. Pentoxifylline in treatment of sarcoidosis. Am J Respir Crit Care Med. 1997;155:1665-1669.

• 摘要

39.  Baughman RP, Culver DA, Cordova FC, et al. Bosentan for sarcoidosis-associated pulmonary hypertension: a double-blind placebo controlled randomized trial. Chest. 2014;145:810-817.

• 摘要

40.  Corte TJ, Wells AU, Nicholson AG, et al. Pulmonary hypertension in sarcoidosis: a review. Respirology. 2011;16:69-77.

• 摘要

41.  Stern BJ. Neurological complications of sarcoidosis. Curr Opin Neurol. 2004;17:311-316.

• 摘要

42.  Baughman RP, Lower EE. Fungal infections as a complication of therapy for sarcoidosis. QJM. 2005;98:451-456.

• 全文
• 摘要